We are pleased to invite you to participate in the Middle East School of Steatotic Liver Disease, a dedicated educational initiative focused on MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) and fatty liver disease.

This scientific program is designed to support hepatogastroenterologists across the Middle East, with the aim of addressing the increasing burden of liver diseases. In 2026, the curriculum will feature a comprehensive SLD module that integrates the latest global research, evolving disease nomenclature, and current best practices in diagnosis, management, and prevention.

Module II will explore MASLD risk assessment and therapeutic interventions, bringing together regional and international experts to discuss the latest evidence, practical management strategies, and emerging treatments.